Search:

Search Results	New Search
Drugs in the non-nucleoside reverse transcriptase inhibitor class (NNRTI) bind to and disable HIV-1's reverse transcriptase enzyme. Without functional reverse transcriptase, HIV replication is halted.

FDA-approved Drugs   Non-nucleoside Reverse Transcriptase Inhibitors   136817-59-9 (Rescriptor)   BI-RG-587 (Viramune)   DLV (Rescriptor)   DMP-266 (Sustiva)   Delavirdine (Rescriptor)   Delavirdine mesylate (Rescriptor)   EFV (Sustiva)   ETR (Intelence)   ETV (Intelence)   Efavirenz (Sustiva)   Etravirine (TMC125) (Intelence)   Intelence (Intelence)   L 743726 (Sustiva)   NVP (Viramune)   Nevirapine (Viramune)   Rescriptor (Rescriptor)   Stocrin (Sustiva)   Sustiva (Sustiva)   TMC 125 (Intelence)   TMC-125 (Intelence)   TMC125 (Intelence)   U-90152S (Rescriptor)   Viramune (Viramune)   Investigational Drugs   Non-nucleoside Reverse Transcriptase Inhibitors   R278474   Rilpivirine   Rilpivirine (TMC278)

Home  |   About Us  |   Contact Us  |   Glossary  |   Site Map  |   Privacy Policy  |   FOIA  |   Accessibility  |   Sponsors       Download Adobe Acrobat® Reader™ to view PDF files located on this site. Download Windows Media Player™ or Apple QuickTime™ to view multimedia files on this site. Site updated: January 30, 2009

We subscribe to the HONcode principles. Verify here